Fortress Biotech
FBIO
48 hedge funds and large institutions have $24M invested in Fortress Biotech in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 4 closing their positions.
267% more capital inflows, than outflows
Capital inflows: $5.67M | Capital outflows: $1.54M
50% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 4
0.85% less ownership
Funds ownership: 13.71% → 12.86% (-0.85%)
6% less funds holding
Funds holding: 51 → 48 (-3)
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.72M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$202K |
| 3 |
State Street
Boston,
Massachusetts
|
+$200K |
| 4 |
Virtu KCG Holdings
New York
|
+$152K |
| 5 |
JP Morgan Chase
New York
|
+$67.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Avoro Capital Advisors
New York
|
-$607K |
| 2 |
Millennium Management
New York
|
-$323K |
| 3 |
Morgan Stanley
New York
|
-$182K |
| 4 |
Citigroup
New York
|
-$102K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$74.4K |
FBIO Hedge Fund Activity: Q1 2017 in Review
48 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q1 2017, worth a combined $24M — up 32% from $18.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new FBIO positions and 4 closed out — a net gain of 2 holders — while 14 added to existing stakes and 16 trimmed.
The largest buyer was BlackRock, adding an estimated $4.72M. The largest seller was Avoro Capital Advisors, cutting an estimated $607K.
- 48 institutional investors held Fortress Biotech (FBIO) as of Q1 2017, down from 51 in Q4 2016.
- Funds reported $24M of Fortress Biotech stock for Q1 2017, up 32% quarter-over-quarter.
- 6 funds opened new Fortress Biotech positions in Q1 2017 and 4 closed out, a net change of +2 holders.
- The largest Fortress Biotech buyer in Q1 2017 was BlackRock, an estimated $4.72M added.
- The largest Fortress Biotech seller in Q1 2017 was Avoro Capital Advisors, an estimated $607K sold.
Based on aggregated 13F filings for Q1 2017.